results released last night:
third quarter Axiron sales revenue 5.2m vs second quarter 2.2m, these being the only full quarters since launch.
as we know the prices are subsidised during the launch phase so at this point i am not focussed on the dollar value, rather the launch trajectory which looks very impressive.
i haven't listened to the whole conf call, so if anyone picked up commentary on specific volumes/mkt penetration pls do share.
- Forums
- ASX - By Stock
- ACR
- eli lilly: 136% qtrly increase in axiron sales
eli lilly: 136% qtrly increase in axiron sales
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
-0.003(4.62%) |
Mkt cap ! $18.02M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 6.0¢ | $15K | 242.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.061 |
2 | 151017 | 0.060 |
3 | 48750 | 0.059 |
2 | 26241 | 0.058 |
1 | 84000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 25000 | 1 |
0.064 | 29999 | 1 |
0.065 | 130000 | 1 |
0.066 | 15395 | 2 |
0.067 | 140000 | 2 |
Last trade - 15.20pm 02/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |